A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
In: Respiratory Medicine Case Reports, Jg. 36 (2022), Heft 101609-
Online
academicJournal
Zugriff:
Anamorelin (ANA) is approved for treating cancer cachexia (CCX) in Japan. We report the case of a 69-year-old man with stage IVB squamous cell lung cancer complicated by CCX, having a 13.6% weight loss in 6 months. After chemotherapy was initiated, his weight was further reduced. Therefore, we started ANA combined with a treatment approach by a multidisciplinary collaboration, including nutritionists and physical therapists. After initiation of ANA, the body weight, appetite, psoas muscle index, and physical functions rapidly improved during chemotherapy. ANA administration combined with a multidisciplinary collaboration approach can be an effective supportive therapy against CCX during chemotherapy.
Titel: |
A case of squamous cell lung cancer treated with anamorelin in combination with a multidisciplinary collaborative approach for treating cancer cachexia
|
---|---|
Autor/in / Beteiligte Person: | Oshima, Yuri ; Matsuura, Hiroyuki ; Sakurai, Yusuke ; Hirai, Kaho ; Tani, Eriko ; Yoshimoto, Naoki ; Minami, Kenichi ; Yamasaki, Fumio ; Nishime, Mayu ; Hirashima, Tomonori |
Link: | |
Zeitschrift: | Respiratory Medicine Case Reports, Jg. 36 (2022), Heft 101609- |
Veröffentlichung: | Elsevier, 2022 |
Medientyp: | academicJournal |
ISSN: | 2213-0071 (print) |
DOI: | 10.1016/j.rmcr.2022.101609 |
Schlagwort: |
|
Sonstiges: |
|